Week 33 of 2025 - Securing Profits and Shedding Dead Weights
Summary Read:
Week 33 delivered steady progress with $1.6k gains, driven by strong options performance (+$3.2k) and offset by stock positions (-$1.6k).
With 52 open positions delivering a 73% win rate, my focus now shifts to managing position sizing and correlation risk.
The HIMS and UNH situations highlight how sector concentration and news risk can quickly overwhelm technical analysis.
Focused on cutting dead weights and reduce my portfolio value by taking real profits.
S&P was up 0.94% and Nasdaq100 by 0.43% on yet another all time high record week before some small profit taking on Fri.
SoFI continue to be my top consistent performer while positions in healthcare stocks UNH and HIMS were hurting.
I also have large short position on RCL and this position will likely hurt me in the future so I’m taking active steps to reduce exposure in coming weeks.
Before going into stock level deep dive, I want to update on my actions taken on the top losers from week 32. The Top 5 losing trades were from SMCI, HOOD, VXX, GDX and GFS with a combined loss of $20.9k.
Of these 5 positions, I’ve exited the trades from HOOD (-$10k) and GFS (-$16.4k) and am working on risk reduction on the rest.
Subscribe to me and click on notifications bell icon to be informed in real time whenever my trades were executed.
Share your opinions or just chat with me. Post your comment in the comment section— if noticed by Tiger officials, you’ll have a chance to receive 50 Tiger Coins as a reward!
Invited as Guest Speaker for Tiger Meetup on 14th Aug
An Evening of Fun and Candid Sharing Among Trading Peers
Thanks for all fellow trader friends that made it on 14th Aug for this face to face meetup. Thanks Tiger Brokers for organizing such events and provide the platform for sharing. If you attended, give a shoutout and comment [Bless]
@Tiger_James Ooi @Optionspuppy @Funkyhunk
Withdrawing trade profits for living expenses and fund other investments
There are many reasons why we all trade, among mine are securing income to fund living expenses, achieve financial freedom earlier and build generational wealth. What are yours?
Regardless of your motivations, remember to take profit.
WW #33 2025 Top 10 Profitable Trades
Top 10 most profitable trades ranged from $2354 to $285.
The week's surprise winner was $AmovaEFund ChiNext S$(CXT.SI)$, my $10k IPO allocation that delivered SGD 1700 profit as the ChiNext ETF surged 17% in its first month. This reinforces the value of systematic IPO participation in trending sectors. I subscribed to this IPO via Tiger IPO Watch with SGD 10k capital.
WW #33 Top 10 Unprofitable Trades
Top 10 most unprofitable trades ranged from $3094 to $23. Four positions exceeded $1k in losses, though the losing tail remained manageable.
Let me break down the key position updates and lessons learned this week.
1. $SoFi Technologies Inc.(SOFI)$ : The Reliable Performer
SoFI Daily Chart
SoFI trades run like well oiled machines, delivering consistent profits week after week. My large short put positions boosted this stock repeatedly into top 3 profitable positions. Stock price rose 7.56% for the week and on track for 4th week of rise and could challenge all time high of $25.11.
Open Positions:
-
129 short puts at strike $20 and $21 expiring between 22nd Aug to 5th Sept.
Trade ideas this week:
-
Priority: Scale into September puts if IV remains attractive, with readiness to accept assignment and transition to covered call strategy at full allocation.
-
If capital is tight due to other trade assignment, take loss on remaining open trades to limit exposure.
2. $UnitedHealth(UNH)$: The Warren Buffet Effect
UNH Daily Chart
I entered UNH with a bullish bias through long calls, but made a tactical error by selling shorter-dated calls below my long strikes when the stock dropped to $240. This created unlimited risk exposure that materialized when Berkshire's acquisition news drove a 21% weekly surge.
Lesson: Never compromise defined-risk strategies for short-term premium collection
Open Positions:
-
3 long calls with strikes between $270 and $300 expiring between 21st Nov and 16th Jan 2026.
-
3 short calls with strikes between $265 to $285 expiring on 22nd and 29th Aug.
Trade ideas this week:
-
Priority: Roll the losing short calls as they expire and manage as it goes.
-
Take loss if UNH breach $380
3. $Royal Caribbean Cruises(RCL)$: The Unsinkable Cruise Liner
RCL Daily Chart
Classic case to remind myself to trade what I see and not trade what I feel. I felt that RCL is overpriced and is forever due for correction soon [Smug]
My bearish bias on RCL stems from valuation concerns at 20x forward earnings for a cyclical business. However, the market clearly sees different fundamentals - perhaps driven by revenge travel demand and operational efficiency gains.
Key lesson: Fighting strong momentum without a clear catalyst is expensive.
My concentrated RCL short position poses significant risk given the stock's resilience near all-time highs. The shallow 17% pullback from a 115% run-up suggests underlying strength that could squeeze my position.
Price popped back up to within 8% from all time high of $355 and looks set to retest if the conditions are ripe.
It will be prudent to reduce my exposure on RCL to protect my portfolio should RCL move higher explosively.
Open Positions:
-
short 325 shares at average cost of $253.13
-
3 short puts $290 strikes expiring between 22nd Aug to 5th Sept.
Trade ideas this week:
-
Priority: Continue to sell new put to replace those expiring ones
-
Take loss if RCL breached $350
4. $Hims & Hers Health Inc.(HIMS)$: The Falling Knife
HIMS Daily Chart
I traded both HIMS and NVO when their partnership breakup happened with accusation of HIMS selling the compounded GLP-1 drugs (legal knockoffs) as compared to peddling for NVO’s Wegovy.
The profit margins for HIMS were certainly better with the compounded drugs but next stage of the brutal breakup is when NVO starts suing HIMS and some other distributors in US.
With HIMS down 60% from highs and trading at attractive valuations, I assumed the market had overreacted to the NVO partnership breakdown. This timing error (entering puts just as the stock cratered another 25%), highlights the danger of trying to catch a falling knife in single-name volatile biotech plays.
These short puts were now deep in the money and most likely risk being exercised.
Open Positions:
-
4 short puts with strikes at $54 and $55 expiring between 22nd Aug to 5th Sept.
Trade ideas this week:
-
Priority: Take up the assignment when short put expires in the money
-
Sell covered calls at holding cost
-
Roll the short puts further dated if still able to incur credits
Community Messages:
Tiger Cash Boost Accounts now can be linked to SRS and CPF. Enjoy the promo for SGD20 free stocks and commission free from now to 31st Dec 2025. You can refer to the promos on Tiger official channels.
Cash Boost Account with CPF and SRS
About the Writer:
-
This journal post reflects writer’s self-analysis of his own trading performance and are meant to be read as entertainment piece.
-
Writer respect differing views from readers and your opinions are welcome. He is happy to engage in constructive discussions to better his trading edge.
-
Some content information and analytical tools used here are from external sources/platforms and resides within paid walls that the writer had paid subscriptions to gain access.
-
The writer aspires to build his trading war chest with $1mil of trading profits and invite readers to witness and share their own journey and struggles on the path of financial freedom.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Share